SelectQuote
SelectQuote sells Medicare insurance policies through licensed agents and a mail-order pharmacy arm.
The call
The insurance business is profitable and growing, but the stock faces a delisting deadline and a DOJ suit that just bankrupted a rival before AI even enters the picture.
SelectQuote helps people find and buy Medicare insurance online. It is the most profitable of three public companies doing this work, but it is in serious trouble: the stock exchange could remove it from trading by September 2026 unless the company fixes accounting problems, a federal lawsuit about false claims threatens bankruptcy (like what just happened to rival GoHealth), and the company raised $350 million in preferred shares that get paid back before regular stock owners. Larger insurance companies like UnitedHealth and Humana control the commissions SelectQuote earns and could squeeze or replace it anytime. AI voice agents could also handle customer calls without human brokers, though SelectQuote has not yet built this. The company itself might survive, but the common stock is a bet on whether the government doesn't force bankruptcy and whether the stock exchange doesn't kick it off before late 2026.
Why
01
AI pressure: None apparent. No frontier AI voice agent deployed yet; conversational bots could eventually replace licensed agent calls but regulation slows this. Could AI do the core job? Only partly.
02
Bigger players: UnitedHealth Group (HealthMarkets) and carriers Humana, Aetna/CVS, Elevance. Carriers set commission rates that fund SelectQuote's whole model, and UnitedHealth runs its own competing eBroker. Could a giant copy it? Yes, easily.
03
What protects it. Licensed-agent relationships, CMS compliance infrastructure, and carrier commission data that a new entrant cannot quickly replicate.
What would change this call
NYSE compliance status update around the September 2026 cure deadline. Shows whether SelectQuote avoids delisting like peer GoHealth did in June 2026.
Outcome or settlement terms of the DOJ False Claims Act suit against SelectQuote. Reveals if penalties restructure commissions the way the GoHealth case did.
SelectQuote's Q4 FY2026 earnings release (Aug/Sept 2026) versus its $1.61 to $1.71 billion revenue guidance. Confirms whether growth and margin trends hold through the crisis period.
Outcome or settlement terms of the DOJ False Claims Act suit against SelectQuote. Reveals if penalties restructure commissions the way the GoHealth case did.
SelectQuote's Q4 FY2026 earnings release (Aug/Sept 2026) versus its $1.61 to $1.71 billion revenue guidance. Confirms whether growth and margin trends hold through the crisis period.
Key numbers
- Q3 FY2026 revenue $430.9M, up 6% YoY
- Stock trading $0.72 to $0.84, down from $33 high
- Market cap around $126M
Named risks
- NYSE delisting if share price compliance not regained by ~September 2026.
- DOJ False Claims Act lawsuit alleging Medicare kickbacks 2016-2021, same suit that bankrupted GoHealth.
- Common equity subordinated to $350M preferred raise, limiting upside for shareholders.
- PBM and CMS reimbursement rate pressure on SelectRx pharmacy margins.
- No shipped AI product while core telephonic sales workflow faces AI-driven competitive compression.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| GoHealth | gaining on | GoHealth filed Chapter 11 and delisted June 2026, potentially freeing carrier lead volume for SelectQuote |
| eHealth | contesting | eHealth posts higher Medicare Advantage LTV ($938-1,154) in 2025-2026 but SelectQuote leads on revenue and GAAP profit, Q1 2026 |
| UnitedHealth Group (HealthMarkets) | losing to | UnitedHealth owns HealthMarkets, a large private eBroker with carrier-side scale advantages, as of 2026 |
| Integrity Marketing | contesting | Private Medicare distribution competitor referenced alongside public eBrokers in 2026 industry analysis |
Questions people ask
- Is SelectQuote profitable in 2026?
- Yes. SelectQuote reported Q3 FY2026 (ended March 31, 2026) net income of $40.2M and Adjusted EBITDA of $44.6M, up 18% YoY, on revenue of $430.9M. It was the only one of the three public Medicare eBrokers to post a GAAP operating profit in Q1 FY2026, per third-party analysis dated 2026-05-28.
- Could AI replace SelectQuote's insurance agents?
- Not entirely as of July 2026. CMS agent-of-record rules require licensed humans for Medicare Advantage and Supplement sales, but the core telephonic lead-qualification workflow is exposed to conversational AI automation. No SelectQuote-branded generative or agentic AI product has been publicly announced as of its May 5, 2026 earnings report.
- Is SelectQuote at risk of being delisted from the NYSE?
- Yes. NYSE issued SelectQuote a non-compliance notice on March 19, 2026 after its average share price fell below $1 for 30 trading days, starting a six-month cure period ending around September 2026. Its market cap was about $126M and stock traded at $0.72 to $0.84 as of July 22, 2026.
- Who is SelectQuote's biggest competitor?
- SelectQuote's closest public peers are GoHealth and eHealth, plus private Integrity Marketing and UnitedHealth Group's HealthMarkets. GoHealth filed for Chapter 11 bankruptcy and was delisted in June 2026 after the same DOJ kickback lawsuit that names SelectQuote, potentially freeing up carrier lead volume for survivors.
- What happened to SelectQuote's stock price?
- SelectQuote's stock fell from an all-time high of $33 to a range of $0.72 to $0.84 as of July 22, 2026, with a 52-week range of $0.56 to $2.77 and a market cap of about $126M, triggering an NYSE non-compliance notice on March 19, 2026.
- Does SelectQuote face legal trouble similar to GoHealth?
- Yes. Both companies are named in a DOJ False Claims Act lawsuit filed May 1, 2025 alleging tens of millions in illegal Medicare kickbacks from 2016 to 2021. GoHealth's version of this exposure contributed to its Chapter 11 filing and delisting in June 2026; SelectQuote's case remains ongoing as of July 2026.
Timeline
- 2026-06-12GoHealth files Chapter 11 and delists, same DOJ lawsuit as SelectQuote names both companies
- 2026-05-05SelectQuote reports Q3 FY2026: revenue $430.9M, net income $40.2M, Adjusted EBITDA $44.6M
- 2026-03-19NYSE issues non-compliance notice to SelectQuote, six-month cure period begins
- 2026-02-05SelectQuote reports Q2 FY2026: revenue $537.1M, net income $69.3M
- 2026-01-15SelectQuote secures $415M credit facility extending debt maturities to 2031; signs new SelectRx PBM deal
- 2025-10-09Securities fraud class action filed in SDNY (Case 1:25-cv-06620) tied to DOJ complaint
- 2025-05-23SelectQuote receives final approval on $8.25M data-privacy settlement over Meta/TikTok pixel tracking
- 2025-05-01DOJ files False Claims Act lawsuit alleging Medicare kickbacks from 2016 to 2021
- 2024-09-04SelectQuote announces third SelectRx fulfillment center in Olathe, Kansas
- 2020-05-21SelectQuote IPOs on NYSE under ticker SLQT
Revision history
23 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- SelectQuote Inc. Profile (2026-03-11)
- SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2026 Results (2026-05-05)
- EBITDA surges 18% on efficiency gains (2026-05-05)
- gurufocus.com (2026-07-23)
- SelectQuote Faces NYSE Listing Compliance Challenge Amid Pressure (2026-03-25)
- SelectQuote (SLQT) Earnings Call Transcripts (2026)
- GoHealth shares sink after Chapter 11 filing, delisting but peers remain unfazed (2026-06-12)
- SelectQuote, Inc. Class Action Lawsuit (2025-10-09)
- Up to $8.25M SelectQuote Settlement Ends Class Action Lawsuit (2025-05-23)
- eBroker Q1 2026 Results (2026-05-28)
- eBroker CY 2025 Results (2026-04-09)
- SelectRx Pharmacy Third Fulfillment Center (2024-09-04)